Search Results

1

$Cost-effectiveness of gilteritinib for relapsed/ refractory FLT3mut+ acute myeloid leukemia$

Cost-effectiveness of gilteritinib for relapsed/ refractory FLT3mut+ acute myeloid leukemia

by Garnham, A., Pandya, B.J, Qi, C.Z, Shah, M.V, Yang, H., Zeidan, A.M
Published 2021

Call Number: Loading...
Located: Loading...

View Fulltext in Publisher

Article
2

IncRNA MVIH correlates with disease features, predicts treatment response and survival in pediatric acute myeloid leukemia

by Duan, Y., Gao, C., Gao, H., Gao, W., Li, N., Li, S., Liu, J., Ren, Y., Xia, H., Xue, H., Zhang, H.
Published 2021

Call Number: Loading...
Located: Loading...

View Fulltext in Publisher

Article
3

Hidradenitis suppurativa in acute myeloid leukemia: Review of disease course and management

by Charrow, A., Chen, S.X, Kassamali, B., Lopez, C.G, Luskin, M.R
Published 2022

Call Number: Loading...
Located: Loading...

View Fulltext in Publisher

Article
4

Linking Ayurveda and Western medicine by integrative analysis

by Bender, A., Fan, T.-P, Fauzi, F.M, Glen, R.C, Joshi, K., Koutsoukas, A., Lowe, R.
Published 2013

Call Number: Loading...
Located: Loading...

View Fulltext in Publisher
View in Scopus

Article
5

Comprehensive analysis of mutations and clonal evolution patterns in a cohort of patients with cytogenetically normal acute myeloid leukemia

by Abdullah, J., Abu Seman, Z., Ahid, F., Esa, E., Kamaluddin, N.R, Mat Yusoff, Y., Zakaria, Z.
Published 2021

Call Number: Loading...
Located: Loading...

View Fulltext in Publisher
View in Scopus

Article